Weight Loss (Lifestyle Modification)
Treatment for Sleep Apnea
Typical Dosage: Sustained caloric deficit, regular exercise
Effectiveness
85%
Safety Score
95%
Clinical Trials
18
Participants
100K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
95
DangerousModerateSafe
Treatment Details
Dosage Range
Sustained caloric deficit, regular exercise
Time to Effect
6-12 months
Treatment Duration
Lifetime
Evidence Quality
HIGHConfidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$100
Side Effect Mgmt:$0
Total Annual:$250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$10,000/QALY
QALYs Gained
1.5
Outcome-Based Costs
Cost per Responder
$357
Cost per Remission
$625
Weight Loss (Lifestyle Modification) Outcomes
for Sleep Apnea
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+70%
Remission Rate
+40%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
4 active trials recruiting for Weight Loss (Lifestyle Modification) in Sleep Apnea
Effect of Weight Loss From ESG Plus Lifestyle Changes vs. Lifestyle Changes Alone in Sleep Apnea Patients
NCT07082608RECRUITINGNA
74 participants
INTERVENTIONAL
Hyderabad, India
Started: Aug 19, 2025
Metabolism and Sleep Apnea Treatment
NCT05539716RECRUITINGNA
100 participants
INTERVENTIONAL
Miami, United States
Started: May 20, 2022
An Interactive Mobile Care on Self-management Among T2DM with OSA
NCT06760715NOT YET RECRUITINGNA
162 participants
INTERVENTIONAL
Miaoli, Taiwan
Started: Dec 30, 2024
Biological Sample Repository for Gastrointestinal Disorders
NCT05874726ACTIVE NOT RECRUITING
500 participants
OBSERVATIONAL
Boston, United States
Started: Jul 19, 2023
Completed Clinical Trials
12 completed trials for Weight Loss (Lifestyle Modification) in Sleep Apnea
Lifestyle Modification Using an App in OSA
NCT03189940COMPLETEDNA
59 participants
INTERVENTIONAL
Started: Jun 20, 2016
Obstructive Sleep Apnea in Obese Children and Teenagers - Occurrence and Importance of Intervention
NCT02463201COMPLETED
236 participants
OBSERVATIONAL
Holbæk, Denmark +1 more
Started: Apr 1, 2015
Effect of Weight Loss and CPAP on OSA and Metabolic Profile Stratified by Craniofacial Phenotype
NCT03287973COMPLETEDNA
194 participants
INTERVENTIONAL
Hong Kong, Hong Kong
Started: Sep 15, 2017
Life-style Changes in Obstructive Sleep Apnea
NCT01102920COMPLETEDNA
86 participants
INTERVENTIONAL
Uppsala, Sweden
Started: May 1, 2010
Lifestyle Intervention in Obstructive Sleep Apnoea
NCT01546792COMPLETEDPHASE2, PHASE3
60 participants
INTERVENTIONAL
Sheffield, United Kingdom +1 more
Started: Jan 1, 2010
Pragmatic Obstructive Sleep Apnea Weight Loss Trial Assessing Effectiveness and Reach
NCT05104450COMPLETEDNA
696 participants
INTERVENTIONAL
Seattle, United States
Started: Apr 4, 2022
Lifestyle Intervention for OSA in Adults
NCT03851653COMPLETEDNA
89 participants
INTERVENTIONAL
Granada, Spain
Started: Apr 1, 2019
The Effectiveness of Smartphone Application on the Serevity of Obstructive Sleep Apnea
NCT05127239COMPLETEDNA
146 participants
INTERVENTIONAL
Miaoli, Taiwan
Started: Oct 15, 2020
Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service
NCT03638895COMPLETEDNA
51 participants
INTERVENTIONAL
Liverpool, United Kingdom
Started: Nov 28, 2018
Cost-effectiveness Study of a Lifestyle Change Program for the Treatment of OSA and Obesity: Hospital-Primary Care.
NCT04296721COMPLETEDNA
90 participants
INTERVENTIONAL
L'Hospitalet de Llobregat, Spain
Started: Jan 1, 2019
Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes
NCT03984058COMPLETEDNA
1 participants
INTERVENTIONAL
Baltimore, United States
Started: Oct 1, 2019
Effects of CPAP on Cognitive Function, Neurocognitive Architecture and Function in Patients With OSA: The SMOSAT Trial
NCT02886156COMPLETEDNA
148 participants
INTERVENTIONAL
Shanghai, China
Started: Apr 4, 2017